Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
With safety steps in place, this treatment lets people have a plan made just for them to fight obesity
Safety endpoints were treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), and discontinuation due to adverse events (AEs)
PMID 39817343
Contraindications for non-diabetic GLP-1 use include pregnancy, personal history of thyroid cancer, and certain gastrointestinal disorders
Serious Risks Glucagon-like peptide-1 receptor agonists (GLP1-RAs), including semaglutide, are linked to an increased risk of serious medical conditions, including: Pancreatitis Gallbladder problems Kidney injury Allergic reactions Pulmonary aspiration during anesthesia Mixing Semaglutide and Alcohol There is no direct interaction between alcohol and semaglutide
.jpg)